Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
16,644,625
-
Share change
-
-207,581
-
Total reported value
-
$220,116,744
-
Price per share
-
$13.22
-
Number of holders
-
76
-
Value change
-
-$2,676,769
-
Number of buys
-
25
-
Number of sells
-
34
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2016
As of 30 Sep 2016,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,644,625 shares.
The largest 10 holders included
Paradice Investment Management LLC, Boston Partners, JANUS CAPITAL MANAGEMENT LLC, HEARTLAND ADVISORS INC, ACK Asset Management LLC, Park West Asset Management LLC, Lapides Asset Management, LLC, Senvest Management, LLC, BANK OF MONTREAL /CAN/, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
76
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.